Cost-Effectiveness and Cost-Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study

Neuromodulation

Volumn 18, Issue 4, 2015, Pages 266-276

  Zucco, Furio ^a   Ciampichini, Roberta ^b   Lavano, Angelo ^c   Costantini, Amedeo ^d   De Rose, Marisa ^c   Poli, Paolo ^e   Fortini, Gianpaolo ^f   Demartini, Laura ^g   De Simone, Enrico ^h   Menardo, Valentino ⁱ   Cisotto, Piero ^j   Meglio, Mario ^k   Scalone, Luciana ^b   Mantovani, Lorenzo G ^b  

^a Azienda Ospedaliera Guido Salvini Garbagnate Milanese   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d Ospedale Clinicizzato SS Annunziata   (Italy)

^e UNIVERSITY HOSPITAL OF PISA   (Italy)

^f OSPEDALE DI CIRCOLO   (Italy)

^g IRCCS   (Italy)

^h S G MOSCATI HOSPITAL   (Italy)

ⁱ S CROCE E CARLE HOSPITAL   (Italy)

^j OSPEDALE CA FONCELLO   (Italy)

^k FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

more..

Author keywords

Cost effectiveness; cost utility; failed back surgery syndrome; quality adjusted life years; Spinal Cord Stimulation

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DISABILITY; FAILED BACK SURGERY SYNDROME; FEMALE; HEALTH CARE COST; HUMAN; LEG PAIN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PAIN INTENSITY; QUALITY OF LIFE; SPINAL CORD STIMULATION; THERAPY RESISTANCE; AGED; CLINICAL TRIAL; ECONOMICS; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; PSYCHOLOGY; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

AGED; COST-BENEFIT ANALYSIS; DISABILITY EVALUATION; FAILED BACK SURGERY SYNDROME; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPINAL CORD STIMULATION; SURVEYS AND QUESTIONNAIRES;

EID: 84930271472     PISSN: 10947159     EISSN: 15251403     Source Type: Journal    
DOI: 10.1111/ner.12292     Document Type: Article

References (41)

1. Thomson S, Jacques L,. Demographic characteristics of patients with severe neuropathic pain secondary to failed back surgery syndrome. Pain Pract 2009; 9: 206-215.
2. Van. Buyten JP, Linderoth B,. The failed back surgery syndrome: definition and therapeutic algorithms-An update. Eur J Pain Supplements 2010; 4: 273-286.
3. Doth AH, Hansson PT, Jensen MP, Taylor RS,. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain 2010; 149: 338-344.
4. Cruccu G, Aziz TZ, Garcia-Larrea L, et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007; 14: 952-970.
5. Shealy CN, Mortimer JT, Reswick JB,. Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report. Anesth Analg 1967; 46: 489-491.
6. Eldabe S, Kumar K, Buchser E, Taylor RS,. An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation 2010; 13: 201-209.
7. Kumar K, Taylor RS, Jacques L, et al. The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery 2008; 63: 762-770.
8. Kumar K, Taylor RS, Jacques L, et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain 2007; 132: 179-188.
9. Taylor RS,. Spinal cord stimulation in complex regional pain syndrome and refractory neuropathic back and leg pain/failed back surgery syndrome: results of a systematic review and meta-analysis. J Pain Symptom Manage 2006; 31 (4 Suppl.): S13-S19.
10. North RB, Kidd D, Shipley J, Taylor RS,. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analysis based on a randomized, controlled trial. Neurosurgery 2007; 61: 361-368.
11. North RB, Ewend MG, Lawton MT, Kidd DH, Piantadosi S,. Failed back surgery syndrome: 5-year follow-up after spinal cord stimulator implantation. Neurosurgery 1991; 28: 692-699.
12. Taylor RS, Taylor RJ,. The economic impact of failed back surgery syndrome. British Journal of Pain 2012; 6: 174-181.
13. Kumar K, Malik S, Demeria D,. Treatment of chronic pain with spinal cord stimulation versus alternative therapies: cost-effectiveness analysis. Neurosurgery 2002; 51: 106-115.
14. Kumar K, North RB, Taylor RS, et al. Spinal cord stimulation versus conventional medical management: a prospective, randomized, controlled,multicenter study of patients with Failed Back Surgery Syndrome (PROCESS study). Neuromodulation 2005; 8: 213-218.
15. Manca A, Kumar K, Taylor RS, et al. Quality of life, resource consumption and costs of spinal cord simulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). Eur J Pain 2008; 12: 1047-1058.
16. Taylor RS, Ryan J, O'Donnell R, Eldabe S, Kumar K, North RB,. The cost-effectiveness of spinal cord stimulation in the treatment of failed back surgery syndrome. Clin J Pain 2010; 26: 463-469.
17. National Institute for Health and Care Excellence. Spinal Cord Stimulation for Chronic Pain of Neuropathic or Ischaemic Origin. London: National Institute for Health and Clinical Excellence, 2008. http://guidance.nice.org.uk/TA159/Guidance/pdf/English
18. Atkinson L, Sundaraj SR, Brooker C, et al. Recommendations for patient selection in spinal cord stimulation. J Clin Neurosci 2011; 18: 1295-1302.
19. North R, Shipley J, Prager J, et al. Practice parameters for the use of spinal cord stimulation in the treatment of chronic neuropathic pain. Pain Med 2007; 8 (Suppl. 4): S200-S275.
20. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005; 113: 9-19.
21. Fairbank JC, Pynsent PB,. The Oswestry Disability Index. Spine (Phila Pa 1976) 2000; 25: 2940-2952.
22. Ware J Jr, Kosinski M, Keller SD,. SF-36 physical and mental health summary scales: a user's manual. Boston (MA): The Health Institute; 1994.
23. Rabin R, de Charro F,. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33: 337-343.
24. National. Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisals, 2008. http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf
25. Italian. National Institute of Statistics (ISTAT). AnnuarioStatisticoItaliano. Roma: Istituto Nazionale di Statistica. Coefficienti per tradurre valori monetari dei periodi sotto indicati in valori del 2009. http://rivaluta.istat.it/Rivaluta/
26. Conferenza. delle Regioni e Province Autonome. Compensazione Interregionale della mobilità sanitaria. TestoUnico. Versione in vigore per le attività dell'anno 2008. Roma, 29 luglio 2009.
27. Demartini L, Mearini M, Beccagutti G, Grifi M, Grabbi E,. Neurostimolazione spinale: analisi dei costi di ospedalizzazione in due centri Lombardi. Poster presented at the 4th National Congress of the Italian Society of HTA (SIHTA), Udine (Italy), November 17-19, 2011.
28. Italian Agency for Regional Healthcare Services (Agenzia Nazionale per i Servizi Sanitari Regionali, Age.na.s). Prestazioni specialistiche ambulatoriali. Confronto tra le tariffe nazionali ex DM 1996 e le tariffe regionali relative all'anno 2009. http://www.agenas.it/monitoraggio-costi-tariffe/2009-SPECIALISTICA-ex%20DM%2096per%20sito.pdf
29. Italian. Ministry of Health. Regolamento recante norme per le prestazioni di assistenza protesica erogabili nell'ambito del Servizio sanitario nazionale: modalità di erogazione e tariffe. Decreto Ministeriale 27 Agosto 1999. Italian Official Gazette n. 227, 27th September 1999.
30. L'informatore farmaceutico-Medicinali 2008. Milano: Elsevier Masson, 2008.
31. Lucioni C, Mangrella M, Mazzi S, Negrini C, Vaghi A,. Impiego di un'associazione fissa di formoterolo e budesonide nel trattamento del paziente asmatico. Una valutazione farmacoeconomica rispetto ad alcune alternative terapeutiche. Pharmacoeconomics-Italian Research Articles 2002; 4: 15-23.
32. Drummond M, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL,. Methods for the Economic Evaluation of Health Care Programmes, 3rd ed. Oxford, UK: Oxford University Press, 2005.
33. Scalone L, Cortesi PA, Ciampichini R, et al. Italian population-based values of EQ-5D health states. Value Health 2013; 16: 814-822.
34. Streiner DL,. The case of the missing data: methods of dealing with dropouts and other research vagaries. Can J Psychiatry 2002; 47: 68-75.
35. Barber JA, Thompson SG,. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 2000; 19: 3219-3236.
36. O'Brien BJ, Briggs AH,. Analysis of uncertainty in healthcare cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res 2002; 11: 455-468.
37. Messori A, Santarlasci B, Trippoli S, Vaiani M,. Drug economic equivalent and clinical benefit: state of the art on methodology and application of a pharmacoeconomic algorithm. Pharmacoeconomics-Italian Research Articles 2003; 5: 53-67.
38. Olivieri I, de Portu S, Salvarani C, et al. The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumor necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy. Rheumatology 2008; 47: 1664-1670.
39. North R, Shipley J, Prager J, et al. Practice parameters for the use of spinal cord stimulation in the treatment of chronic neuropathic pain. Pain Med 2007; 8 (Suppl. 4): S200-S275.
40. Badia X, Roset M, Herdman M, Kind P,. A comparison of United Kingdom and Spanish general population time-trade-off values for EQ-5D health states. Med Decis Making 2001; 21: 7-16.
41. Budd K,. Spinal cord stimulation: cost-benefit study. Neuromodulation 2002; 5: 75-78.